SLC6A3 and Parkinson disease: The main objective of the study was the assessment of cerebral glucose metabolism.Decreased striatal tracer uptake in iRBD and PD patients compared with controls (iRBD patients presented with an intermediate state in striatal DAT between PD and normal controls).